Shelter Pharma Limited Secures $1,41,600 International Order from Sudan-Based Client

1 min read     Updated on 23 Jan 2026, 12:12 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Shelter Pharma Limited has secured an international order worth $1,41,600 from Sudan-based Taha Drugs & Chemicals Co. Ltd for Joemega Capsule strips. The fixed-cost contract is to be executed within two months and represents a noteworthy addition to the company's international business portfolio. The transaction maintains full regulatory compliance with no related party involvement.

30696134

*this image is generated using AI for illustrative purposes only.

Shelter Pharma Limited has secured a noteworthy international order worth $1,41,600 from Taha Drugs & Chemicals Co. Ltd, a Sudan-based pharmaceutical entity. The company announced this development through a regulatory filing under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.

Order Details and Specifications

The secured order encompasses Joemega Capsule 3*10 Strips (BOX), representing a fixed-cost contract with the international client. The order details are structured as follows:

Parameter Details
Client Name Taha Drugs & Chemicals Co. Ltd
Product Joemega Capsule 3*10 Strips (BOX)
Order Value $1,41,600
Client Location Sudan (International)
Contract Type Fixed cost
Execution Timeline Within 2 months

Regulatory Compliance and Transaction Structure

The company has confirmed that this international order maintains full regulatory compliance and transparency. Key compliance aspects include:

  • The transaction does not fall within related party transactions
  • Promoters and promoter group companies have no interest in the awarding entity
  • The contract represents an arm's length transaction with the Sudan-based client
  • Full disclosure has been made as per SEBI regulations

Company Profile and Market Position

Shelter Pharma Limited operates as a leading pharmaceutical and nutraceutical company with a focus on research, innovation, and quality standards. The company maintains state-of-the-art facilities and employs world-class expertise to deliver products adhering to industry standards. Their product portfolio spans pharmaceuticals and nutraceuticals, with a mission to provide accessible healthcare solutions globally.

The company's commitment to ethical practices and innovation has established its reputation as a trusted name in the pharmaceutical industry. This international order from Sudan demonstrates the company's expanding global reach and market acceptance of its pharmaceutical products.

Historical Stock Returns for Shelter Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-4.18%-0.12%-23.04%-26.86%-19.17%-21.33%

Shelter Pharma Secures ₹27,540 Order from Sudan Partner for D3 Cure Capsules

1 min read     Updated on 16 Dec 2025, 11:17 AM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Shelter Pharma Limited announced securing another international order worth ₹27,540 from Sudan-based Taha Drugs & Chemicals Co. Ltd for D3 Cure Capsules. This represents the third order from the same client, following previous orders worth ₹98,875 and ₹27,600, demonstrating continued business expansion in international markets with execution timeline of 2 months.

23957710

*this image is generated using AI for illustrative purposes only.

Shelter Pharma Limited , a pharmaceutical and nutraceutical company, has announced securing another international order from Taha Drugs & Chemicals Co. Ltd, a Sudan-based entity. The latest order is worth ₹27,540 for D3 Cure Capsules, adding to the company's growing international business portfolio.

Latest Order Details

The recent order announcement provides the following specifications:

Aspect: Details
Product: D3 Cure Capsules
Order Value: ₹27,540
Execution Timeline: Within 2 months
Client Location: Sudan (International entity)
Related Party Transaction: No

Previous Order History

This marks the third order from the same Sudan-based client, demonstrating a continued business relationship with the international partner. The company has previously secured orders including one worth ₹98,875 for Joemega Capsules and Vitamin Tablets, and another worth ₹27,600 for Joemega Capsules.

Order Comparison: Previous Orders Latest Order
Order Values: ₹98,875 & ₹27,600 ₹27,540
Products: Joemega Capsules & Vitamin Tablets D3 Cure Capsules
Timeline: Within 2 months Within 2 months

Regulatory Compliance

Shelter Pharma Limited has confirmed that this latest order does not constitute a related party transaction. The company's promoters have no interest in Taha Drugs & Chemicals Co. Ltd, ensuring transparency in operations and compliance with regulatory requirements under SEBI regulations.

Company Profile

Shelter Pharma Limited positions itself as a leading pharmaceutical and nutraceutical company dedicated to research, innovation, and quality healthcare solutions. The company operates state-of-the-art facilities and maintains a commitment to ethical practices, focusing on producing safe and effective products that enhance quality of life globally.

These consecutive orders from the Sudan-based partner indicate strengthening international relationships and demonstrate the company's ability to secure diverse product orders across different therapeutic segments, which may contribute positively to the company's financial performance.

Historical Stock Returns for Shelter Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-4.18%-0.12%-23.04%-26.86%-19.17%-21.33%

More News on Shelter Pharma

1 Year Returns:-19.17%